Sab Biotherapeutics (SABS)'s 30-day implied volatility (IV30) was 65.7% at the close on October 16, 2026, down from 66.0% the day before, against a 52-week range of 47.8% to 155.0%. Its 20-day historical volatility was 67.7%.
Data as of October 16, 2026.